<GlossaryTerm id="CDR0000269877"><TermName>efaproxiral</TermName><TermPronunciation>(eh-fuh-PROK-sih-rul)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of brain tumors and some other types of cancer. It increases the amount of oxygen in tumor tissues, which may make the tumor cells easier to kill with radiation therapy. Efaproxiral is a type of radiosensitizing agent. Also called RSR13.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710170" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;efaproxiral&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710169" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;efaproxiral&quot;" language="es" id="_4"/><SpanishTermName>efaproxiral</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de tumores cerebrales y algunos otros tipos de cáncer. Aumenta la cantidad de oxígeno en los tejidos tumorales, lo que hace que sea más fácil destruir las células cancerosas con radioterapia. El efaproxiral es un tipo de radiosensibilizador. También se llama RSR13.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-01-26</DateFirstPublished><DateLastModified>2012-06-19</DateLastModified></GlossaryTerm>
